FRESH DATA. EXPERT SPEAKERS. DEEP CONTENT.
This May, researchers from pharma, academia, and biotech will descend on San Diego for two days of networking and content on the challenges to the antibody industry presented by the increased demand for antibody drugs to fight chronic illnesses.
With demand comes innovation. The only antibody event with new data and non-repetitive talks as a requirement to speak, Americas Antibody Congress 2017 will feature sessions on New Data in Antibody Discovery, New Data in Clinical and Commercial Development, and the therapeutic areas of Infectious Diseases and Oncology.
Discover. Develop. Get to market. For Biotech, Pharma, and Their Partners.
The demand for innovation in immunotherapy can only grow, and new breakthroughs are needed if success rates are to continue. That’s why World Immunotherapy Congress is coming to the USA after an acclaimed launch in Europe. This inaugural event will bring together the brightest and best minds in pharma, biotech, government and academia to build on the development and commercialization of new immunotherapy treatments.
Co-located with the Americas Antibody Congress, Immunotherapy World Congress USA features 2 days of in-depth case studies and discussions around Cell Therapy Strategies, Pre-Clinical Development and Innovative Therapeutic Approaches presented by our partners from biopharma and academia.
2017 Speakers include:
Register now: https://goo.gl/8ZgGhe
This congress brings together over 250 key opinion leaders and senior industry experts in drug discovery, to discuss the latest innovative discovery strategies in different therapeutic areas as well as the most effective enabling technologies and solutions.
Including 6 interactive streams
14 pre-scheduled one to one meetings, exhibition and informal networking opportunities.
Co-located with our 5th Annual Discovery Chemistry and Drug Design Congress and our inaugural Microbiome Discovery and Development Congress
Free Webinars available:
Drug Discovery Open Innovation & Outsourcing
Hosted by Patrick Kleyn, Director of Drug Target Innovation, EMD Serono
Register for Free Today: http://bit.ly/2f046Yl
Phenotypic Screening in Drug Discovery- Novel Tools & Applications
Hosted by Paul Andrews, Director of Operations, National Phenotypic Screening Centre (NPSC), School of Life Sciences, University of Dundee
Register for Free Today: http://bit.ly/2f44Xpd
Disruptive Technologies & Artificial Intelligence in Drug Discovery
Hosted by Chris Gibson, CEO, Recursion Pharmaceuticals
Register for Free Today: http://bit.ly/2f4a34F
You can also follow us on Twitter @drugdiscovery1 and join the congress conversation on #DDSummit17
For further information on the congress and the webinars, please contact Guillaume Alonso on firstname.lastname@example.org or call +44 (0) 1865 248 455.
Oxford Global Conferences are proud to present the 2nd Annual Biomarkers & Precision Medicine USA Congress co-located with our 4th Annual Drug Discovery USA Congress, taking place on the 09-10 October 2017 in San Diego, USA.
Over 250 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions.
Over 40 presentations, case studies and panel discussions focused on the key issues in biomarker research, companion diagnostics, personalised medicine and clinical biomarkers.
5 Interactive Streams:
14 pre-scheduled one to one meetings, exhibition and informal networking opportunities. This event is co-located with our 4th Annual Drug Discovery USA Congress.
Translational Biomarkers and Companion Diagnostics Development Consortium
22nd June 2017, 9 am. PST, 12 noon EST, 5 pm. BST
Click here to register today, for free.
Scientific and Regulatory Considerations for the Analytical Validation of Assays for the Qualification of Biomarkers
8th August 2017, 9 am. PST, 12 noon EST, 5 pm. BST
Click here to register today, for free.
Can’t make the dates? Still register and a copy of the webinar recording will be sent to you.For further information, click here: http://bit.ly/22r99ki
The 9th World Congress of Melanoma and the 14th International Congress of the Society for Melanoma Research will be held from 18th to 21st October 2017 in Brisbane, Australia. The joint meeting will bring together the world’s leading melanoma researchers and clinicians to showcase the latest developments in melanoma diagnosis, treatment and research.
This global summit will accelerate scientific and clinical investigations into melanoma, providing an opportunity for delegates from multi-disciplinary fields to meet in a warm climate to exchange knowledge and expertise.
We plan to inspire new partnerships and innovations, and will offer a range of significant benefits to international delegates from across the world, including opportunities to explore new professional horizons that pivot from a uniquely global focus on melanoma and skin cancer control.
The NCRI Cancer Conference is the largest annual cancer research meeting in the UK, attracting over 1,500 participants from across the spectrum of basic, translational and clinical research. We are committed to share and make available to all attendees the best cancer research from all over the world and encourage cross-pollination. The Conference provides a high profile platform where key stakeholders of cancer research come together to discuss, present and showcase high-quality research. The programme covers six main themes - Diagnosis and therapy, Epidemiology and prevention, Health services research, Information, patients and the public, Survivorship and end of life care and the cancer cell and model systems – which are organised in sessions across 4 days. The Conference programme includes plenty of networking opportunities, allowing participants to make the most of their time in Liverpool.
Abstract submission: 3 April – 4 June
Earlybird registration: 3 April – 30 June
Standard registration: 1 July – 22 October
Late breaking abstract submission: 31 July – 28 August